Acute Lymphoblastic Leukemia Patient Stories
1 - 10 of 36
Philadelphia-positive Acute Lymphoblastic Leukemia and Pancreatic Pseudocyst: Colin’s Story
Teams from CHOP oncology, CHOP GI and Penn Medicine partnered to treat Colin’s high-risk leukemia and pancreas complications rarely seen in children.
Endocrine Late Effects After Cancer Treatment: Raine’s Story
Treatment for childhood leukemia has had several long-term effects on Raine’s health, but this successful college graduate is pursuing her dream.
Acute Lymphoblastic Leukemia: Jack’s Story
After Jack was diagnosed with cancer, his family was impressed how everyone at CHOP, from the check-in team to the world-class doctors, made them feel special.
T-cell Acute Lymphoblastic Leukemia: Michael’s Story
Chemotherapy damaged the bone tissue in Michael’s legs, requiring surgery and the use of a wheelchair for several months.
Relapsed T-cell acute lymphoblastic leukemia: Mia’s Story
Five-year-old Mia has spent a great amount of time isolated because of her weakened immune system. Now she can’t wait to ride roller coasters.
Relapsed Acute Lymphoblastic Leukemia: Thomas’ Story
When Thomas was 2 and being treated for leukemia, he was terrified. When the cancer returned, he faced it bravely.
Acute Lymphoblastic Leukemia: Donor-funded Research Helps Lizzy Dance Again
The side effects of cancer treatment challenged 10-year-old Lizzy’s identity as athletic and strong. Now in remission, she’s bouncing back.
Acute Lymphoblastic Leukemia: Donor-supported Research Will Find New Treatments
Desi, 3, has made it through the bad side effects of leukemia treatment. His mature and independent personality is again shining through.
Psychosocial Services for Cancer Patients: Jake’s Story
CHOP’s Cancer Center helps families manage the extreme emotions elicited by a child’s cancer diagnosis through its world-class, comprehensive, innovative psychosocial services.
Down Syndrome and Humanized CAR T-cell Therapy for Relapsed Acute Lymphoblastic Leukemia: Steven’s Story
Chemo is tough on cancer patients with Down syndrome like Steven, so when his leukemia came back, he traveled to CHOP for an experimental cell therapy.